76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Abbott Laboratories
Open
SectorHealthcare
132.45 0.16
Overview
Share price change
24h
Min
131.59
Max
133.35
Income | -7.9B 1.3B |
|---|---|
Sales | -616M 10B |
P/E Sector Avg | 17.381 50.857 |
EPS | 1.09 |
Dividend yield | 1.76 |
Profit margin | 12.792 |
Employees | 114,000 |
EBITDA | -324M 2.7B |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +8.3% upside |
Dividend yield Sector Avg | 1.76% 2.35% |
|---|---|
Next Dividend date | 15 Aug 2025 |
Next Ex Dividend date | 15 Jul 2025 |
Market Cap | 8.1B 236B |
|---|---|
Previous open | 132.29 |
Previous close | 132.45 |
News Sentiment
By Acuity
32%
68%
92 / 381 Healthcare
Technical Score
By Trading Central
Confidence
Weak Bullish Evidence
Abbott Laboratories Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Abbott Laboratories Forecast
Price Target
By TipRanks
8.3% upside
12 Months Forecast
Average 143.26 USD 8.3%
High 159 USD
Low 127 USD
Based on 21 Wall Street analysts offering 12 month price targets forAbbott Laboratories - Dist in the last 3 months.
Sentiment
By Acuity
92 / 381 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
